Support & Action Center

Were you aware that the FDA is currently in an active review period for testosterone's Schedule III controlled substance classification?

Were you aware that there is currently no FDA-approved testosterone formulation for women anywhere in the United States?

Were you aware that testosterone's Schedule III classification was originally enacted in response to sports doping concerns in the 1990s, not clinical evidence of harm in medically supervised use?

To what extent do you support removing testosterone from the Schedule III controlled substance classification?

To what extent do you support the FDA prioritizing the development and approval of a testosterone formulation specifically designed for women?

To what extent do you support the formal recognition of testosterone deficiency as a diagnosed medical condition, enabling insurance coverage for treatment?

To what extent do you support expanding telehealth access for testosterone prescribing regardless of state of residence?

To what extent do you support the current administration using a National Priority Review Voucher to fast-track FDA approval of a testosterone formulation specifically designed for women?

Do you believe the FDA will make the right decision on testosterone scheduling without sustained public pressure from patients, clinicians, and advocacy organizations?

Do you support The Testosterone Project and allied medical organizations sending a formal letter to the FDA and DEA urging descheduling before a regulatory decision is rendered?

Do you support companies, organizations, and institutions publicly signing on to TTP's advocacy position as a visible coalition?

If the federal government could take only one action on testosterone access and policy right now, which of the following should it be?

How urgent do you consider the FDA's current review period for testosterone scheduling to be?

Do you believe women's access to testosterone therapy should be formally designated as a national health priority by the federal government?

Have you ever contacted an elected official about a healthcare issue?

Would you be willing to contact your Congressional representative specifically about testosterone access and scheduling policy?

Would you add your name to a public coalition letter to the FDA and DEA urging action on testosterone access and descheduling?

May The Testosterone Project include anonymized versions of your responses as part of formal regulatory submissions, Congressional briefings, or public comment filings with the FDA or DEA?

If you could say one thing directly to the FDA, the DEA, or your elected representative about testosterone access and policy, what would it be?

Optional

Submission Confirmation

Confirm that the information provided is accurate to the best of your knowledge.